The First Affiliated Hospital of China Medical University initiated a multi-center study to evaluate the changes of maternal fetal heart structure and function in pregnancies with cardiovascular disease by echocardiography, to explore the impact of cardiovascular disease on maternal fetal heart, so as to provide an important reference for obstetric pregnancy risk stratification and management.
Globally, the incidence rate of pregnancy with cardiovascular disease is about 1-4%, and about 15% of maternal deaths are caused by pregnancy with cardiovascular disease related complications. With the opening of China's three children policy and the increase of older mothers, the proportion of maternal deaths caused by pregnancy combined with cardiovascular disease has increased year by year, which has become the primary cause of death of critically ill pregnancies in China. In addition, maternal cardiovascular disease is also the cause of fetal growth and development, cardiac structure abnormalities, and myocardial function damage. Therefore, early sensitive detection of changes in maternal and fetal cardiac structure and function during pregnancy, accurate risk assessment of pregnancy, detailed risk stratification, timely intervention and early evaluation of therapeutic efficacy can greatly reduce maternal mortality and ensure maternal and fetal safety. Echocardiography is the preferred method for maternal fetal heart examination during pregnancy, because it is safe and convenient, and has no radiation risk to pregnancies and fetus. It can accurately and quickly measure and evaluate cardiac cavity size, hemodynamic changes and cardiac function, and can timely detect changes in the structure and function of pregnancies and fetuses at an early stage, and conduct continuous follow-up and close monitoring in different periods of pregnancy. In recent years, most of the domestic and foreign studies on the evaluation of echocardiography in pregnancy with cardiovascular disease are single center, small sample studies, mostly for a single disease, and the follow-up time is short. Some research results are contradictory and controversial, which can not accurately reflect the maternal fetal heart changes in pregnancy with cardiovascular disease. Therefore, it is urgent to conduct a large sample, multi-center study on the evaluation of cardiovascular disease in pregnancy by echocardiography in order to provide important reference and value for the stratification and management of pregnancy risk. In conclusion, this study used echocardiography to evaluate the changes of maternal and fetal cardiac structure and function in pregnancies with cardiovascular disease, and to explore the impact of cardiovascular disease on maternal and fetal cardiac structure and function, so as to provide an important reference for obstetric pregnancy risk stratification and management, and help clinical monitoring and management of pregnancy with cardiovascular disease.
Study Type
OBSERVATIONAL
Enrollment
200
Maternal and fetal echocardiography:Time points for heart image acquisition in pregnant women: As per the Guidelines for Pre-pregnancy and Pregnancy Health Care (2018) formulated by the Obstetrics Group of the Gynecology Branch of the Chinese Medical Association, a total of five echocardiographic examinations will be performed in the first trimester(11-14 weeks of gestation), the second trimester(20-24 weeks of gestation), the third trimester(29-32 weeks of gestation), prenatal term (37-40 weeks of gestation), and 3-6 months after delivery. Time points for fetal heart image acquisition: Fetal heart images will be collected in the second trimester(20 to 24 weeks of gestation).
Jiamusi Central Hospital
Jiamusi, Heilongjiang, China
RECRUITINGThe Third Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
RECRUITINGLeft ventricular ejection fraction
To Evaluate of the changes of maternal cardiac systolic function in pregnancies with cardiovascular disease
Time frame: From 11 weeks of gestation to 3-6 months postpartum
left ventricular global longitudinal strain
To Evaluate of the subclinical changes of maternal cardiac systolic function in pregnancies with cardiovascular disease
Time frame: From 11 weeks of gestation to 3-6 months postpartum
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Dalian Municipal Women and Children's Medical Center
Dalian, Liaoning, China
RECRUITINGWomen And Children's Hospital of Jinzhou
Jinzhou, Liaoning, China
RECRUITINGShenyang Maternity And Child Health Hospital
Shenyang, Liaoning, China
RECRUITINGthe First Hospital of China Medical Univeristy
Shenyang, Liaoning, China
RECRUITINGShengjing Hospital of China Medical University
Shenyang, Liaoning, China
RECRUITINGShaanXi Province People's Hospital
Xi'an, Shaanxi, China
RECRUITINGWeifang Maternal and Child Health Hospital
Weifang, Shandong, China
RECRUITINGYunnan Maternal And Child Health Care Hospital
Kunming, Yunnan, China
RECRUITING